Background/Aims: The bis-indole alkaloid Fascaplysin is effective against malignancy, an effect at least partially due to stimulation of tumor cell apoptosis. Similar to apoptosis of nucleated cells, erythrocytes could enter suicidal erythrocyte death or eryptosis, characterized by cell shrinkage and cell membrane scrambling with phosphatidylserine translocation to the erythrocyte surface. Triggers of eryptosis include increase of cytosolic Ca 2+ activity ([Ca 2+ ] i ), oxidative stress and ceramide. The present study explored, whether Fascaplysin induces eryptosis and, if so, to shed light on the cellular mechanisms involved. Methods: Flow cytometry was employed to estimate phosphatidylserine exposure at the cell surface from annexin-V-binding, cell volume from forward scatter, [Ca 2+ ] i from Fluo3-fluorescence, ROS formation from DCFDA dependent fluorescence, and ceramide abundance utilizing specific antibodies. Hemolysis was quantified from the hemoglobin concentration in the supernatant. Results: A 48 hours exposure of human erythrocytes to Fascaplysin (≥ 5 µM) significantly increased the percentage of annexin-V-binding cells, significantly decreased forward scatter, and significantly increased Fluo3-fluorescence, DCFDA fluorescence as well as ceramide abundance. The effect of Fascaplysin on annexin-V-binding and forward scatter was significantly blunted but not abolished by removal of extracellular Ca 2+ . Conclusions: Fascaplysin triggers cell shrinkage and phospholipid scrambling of the erythrocyte cell membrane, an effect at least in part due to Ca 2+ entry, oxidative stress and ceramide.
Introduction
The marine sponge-derived bis-indole alkaloid Fascaplysin is effective against malaria [1] , against bacterial, fungal, and viral infections [1] , as well as against malignancy [1] [2] [3] . The efficacy against malignancy is at least in part due to activation of autophagy and apoptosis of tumor cells [2, 3] . Fascaplysin further counteracts angiogenesis by triggering apoptosis of endothelial cells [4] . Cellular mechanisms involved include inhibition of p56 tyrosine kinase and of cyclin-dependent kinase-4 [1, 4] , DNA intercalation [1] as well as activation of caspases [2] .
In analogy to apoptosis of nucleated cells, erythrocytes may experience eryptosis [5] , the suicidal death of erythrocytes characterized by cell shrinkage [6] and cell membrane scrambling with breakdown of phospholipid asymmetry and translocation of phosphatidylserine to the cell surface [5] . Eryptosis may be triggered by a variety of cellular mechanisms including increase of cytosolic Ca 2+ activity ([Ca 2+ ] i ) [5] , ceramide [7] , oxidative stress [5, 8] , energy depletion [5] , and activated caspases [5, 9, 10] . Eryptosis is further stimulated by casein kinase 1α, Janus-activated kinase JAK3, protein kinase C, p38 kinase and PAK2 kinase [5] . Eryptosis is inhibited by AMP activated kinase AMPK [5] , cGMP-dependent protein kinase [5] , mitogen-and stress-activated kinase MSK1/2 [11] , sorafenib/sunitinib sensitive kinases [5] and the divalent metal transporter 1 [12] . Eryptosis is stimulated by a wide variety of xenobiotics [5, .
The present study explored, whether Fascaplysin is capable to stimulate eryptosis. Eryhrocytes drawn from healthy volunteers were exposed to Fascaplysin and phosphatidylserine surface abundance, cell volume, [Ca 2+ ] i , as well as abundance of reactive oxygen species (ROS), and ceramide determined by flow cytometry.
Materials and Methods

Erythrocytes, solutions and chemicals
Fresh Li-Heparin-anticoagulated blood samples were kindly provided by the blood bank of the University of Tübingen. The study is approved by the ethics committee of the University of Tübingen (184/2003 V). The blood was centrifuged at 120 g for 20 min at 21°C and the platelets and leukocytes-containing supernatant was disposed. Erythrocytes were incubated in vitro at a hematocrit of 0.4% in Ringer solution containing (in mM) 125 NaCl, 5 KCl, 1 MgSO 4 , 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES; pH 7.4), 5 glucose, 1 CaCl 2 , at 37°C for 48 hours. Where indicated, Fascaplysin (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was added and/or CaCl 2 was removed and 1 mM EGTA added.
Annexin-V-binding and forward scatter
After incubation under the respective experimental condition, a 150 µl cell suspension was washed in Ringer solution containing 5 mM CaCl 2 and then stained with Annexin-V-FITC (1:200 dilution; ImmunoTools, Friesoythe, Germany) in this solution at 37°C for 15 min under protection from light. The annexin-Vabundance at the erythrocyte surface was subsequently determined on a FACS Calibur (BD, Heidelberg, Germany). Annexin-V-binding was measured with an excitation wavelength of 488 nm and an emission wavelength of 530 nm. A marker (M1) was placed to set an arbitrary threshold between annexin-V-binding cells and control cells. The same threshold was used for untreated and Fascaplysin treated erythrocytes. A dot plot of forward scatter (FSC) vs. side scatter (SSC) was set to linear scale for both parameters. The threshold of forward scatter was set at the default value of "52".
Hemolysis
Following incubation, the erythrocyte suspension was centrifuged for 3 min at 1600 rpm, 4°C, and the supernatants were harvested. As a measure of hemolysis, the hemoglobin (Hb) concentration of the supernatants was determined photometrically at 405 nm. The absorption of the supernatant of erythrocytes lysed in distilled water was defined as 100% hemolysis. 
Intracellular
Reactive oxygen species (ROS)
Oxidative stress was estimated utilizing 2',7'-dichlorodihydrofluorescein diacetate (DCFDA). After incubation, a 150 µl suspension of erythrocytes was washed in Ringer solution and stained with DCFDA (Sigma, Schnelldorf, Germany) in Ringer solution containing DCFDA at a final concentration of 10 µM. Erythrocytes were incubated at 37°C for 30 min in the dark and washed two times in Ringer solution. The DCFDA-loaded erythrocytes were resuspended in 200 µl Ringer solution and ROS-dependent fluorescence intensity was measured at an excitation wavelength of 488 nm and an emission wavelength of 530 nm on a FACS Calibur (BD).
Ceramide abundance
For the determination of ceramide, a monoclonal antibody-based assay was used. To this end, cells were stained for 1 hour at 37°C with 1 µg/ml anti ceramide antibody (clone MID 15B4, Alexis, Grünberg, Germany) in PBS containing 0.1% bovine serum albumin (BSA) at a dilution of 1:10. The samples were washed twice with PBS-BSA. The cells were stained for 30 minutes with polyclonal fluorescein isothiocyanate (FITC) conjugated goat anti-mouse IgG and IgM specific antibody (Pharmingen, Hamburg, Germany) diluted 1:50 in PBS-BSA. Unbound secondary antibody was removed by repeated washing with PBS-BSA. The samples were analyzed by flow cytometric analysis with an excitation wavelength of 488 nm and an emission wavelength of 530 nm. As a control, secondary antibody alone was used.
Statistics
Data are expressed as arithmetic means ± SEM. As indicated in the figure legends, statistical analysis was made using ANOVA with Tukey's test as post-test and t test as appropriate. n denotes the number of different erythrocyte specimens studied. Since different erythrocyte specimens used in distinct experiments are differently susceptible to triggers of eryptosis, the same erythrocyte specimens have been used for control and experimental conditions.
Results
The present study addressed the potential impact of Fascaplysin on eryptosis, the suicidal erythrocyte death characterized by cell shrinkage and phosphatidylserine translocation to the cell surface.
Forward scatter determined utilizing flow cytometry was taken as measure of erythrocyte volume. Prior to measurements, the erythrocytes were incubated for 48 hours in Ringer solution without or with Fascaplysin (1 -10 µg/ml). As illustrated in Fig. 1A ,B, Fascaplysin decreased the average erythrocyte forward scatter, an effect reaching statistical significance at 5 µM Fascaplysin concentration. As apparent from the histogram, Fascaplysin increased the percentage of both, shrunken and swollen erythrocytes (Fig. 1A,C,D) .
Annexin-V-binding determined by flow cytometry was employed to identify phosphatidylserine exposing erythrocytes. Prior to measurements, the erythrocytes were again incubated for 48 hours in Ringer solution without or with Fascaplysin (1 -10 µM). As shown in Fig. 2 , a 48 hours exposure to Fascaplysin increased the percentage of phosphatidylserine exposing erythrocytes, an effect reaching statistical significance at 5 µM Fascaplysin.
Hemoglobin concentration in the supernatant was taken as a measure of hemolysis. Prior to measurements, the erythrocytes were again incubated for 48 hours in Ringer solution without or with Fascaplysin (1 -10 µM). As a result, the percentage of hemolysed erythrocytes tended to be higher following a 48 hours exposure in the presence of 1 µM Fascaplysin (5.3 ± 1%, n = 10), 5 µM Fascaplysin (5 ± 0.4%, n = 10), and 10 µM Fascaplysin (5.7 ± 0.7%, n = 10) than in the absence of Fascaplysin (3.4 ± 0.1%, n = 10), differences, however, not reaching statistical significance. A further stimulator of eryptosis is ceramide. Ceramide abundance at the erythrocyte surface was thus quantified utilizing specific antibodies. As shown in Fig. 6 , a 48 hours exposure to 10 µM Fascaplysin significantly increased the ceramide abundance.
Discussion
The present observations reveal a novel effect of Fascaplysin, i.e. the stimulation of eryptosis, the suicidal erythrocyte death. Exposure of erythrocytes from healthy volunteers to Fascaplysin results in cell shrinkage and phospholipid scrambling of the cell membrane, the two hallmarks of eryptosis. . Cells could be sensitized for the scrambling effect of Ca 2+ by ceramide [5] . Fascaplysin indeed enhanced the ceramide abundance. Moreover, eryptosis could be triggered by oxidative stress [5] . Fascaplysin indeed enhanced the abundance of reactive oxygen species.
The effect of Fascaplysin on cell shrinkage is presumably similarly due to Ca 2+ entry from the extracellular space. An increase of [Ca 2+ ] i leads to activation of Ca 2+ sensitive K + channels, K + exit, cell membrane hyperpolarization, Cl -exit and thus to cellular loss of KCl with water [6] . The Fascaplysin concentrations required for the stimulation of eryptosis are well in the range of concentrations encountered in the plasma of patients [57] . The sensitivity to stimuli of eryptosis may be enhanced in several clinical conditions, such as dehydration [58] , hyperphosphatemia [59] , chronic kidney disease (CKD) [60] [61] [62] [63] , hemolytic-uremic syndrome [64] , diabetes [65] , hepatic failure [66] , malignancy [5] , sepsis [67] , sickle-cell disease [5] , beta-thalassemia [5] , Hb-C and G6PD-deficiency [5] , as well as Wilsons disease [68] . The sensitivity to triggers of eryptosis is further a function of erythrocyte age [5, [69] [70] [71] [72] [73] .
Consequences of eryptosis include rapid clearance of affected erythrocytes from circulating blood [5] . Stimulation of eryptosis may lead to anemia as soon as the loss of erythrocytes surpasses the formation of new erythrocytes by erythropoiesis [5] . The adherance of phosphatidylserine exposing erythrocytes to the vascular wall [74] may further stimulate blood clotting and trigger thrombosis [75] [76] [77] , thus impairing microcirculation [7, 75, [78] [79] [80] [81] .
In conclusion, Fascaplysin triggers eryptosis with cell shrinkage and cell membrane scrambling, an effect at least partially due to Ca 2+ entry, oxidative stress and ceramide. 
